Methyl α-D-mannopyranoside for COVID-19

 Methyl α-D-mannopyranoside has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed methyl α-D-mannopyranoside in detail.
Kawsar et al., Molecular Docking against SARS-CoV-2 Variants, Antiviral, Dynamics and Quantum Chemical Modeling of Mannopyranoside Derivatives, Moroccan Journal of Chemistry, doi:10.48317/IMIST.PRSM/morjchem-v11i04.42045
Researchers worldwide are prompting their hard and soul effort to develop the best possible therapeutic options to eliminate vaccination-related difficulties to effectively manage SARS-CoV-2, which is now sweeping the world. The present study was undertaken to investigate the computational properties of methyl α-D-mannopyranoside and its designed derivatives to assess their thermophysical and biochemical parameters. The PASS prediction score was reported to be 0.233